<DOC>
	<DOCNO>NCT01777425</DOCNO>
	<brief_summary>State-of-the-art document like ARIA european position paper rhinosinusitis ( EPOS ) provide clinicians evidence-based treatment algorithm allergic rhinitis ( AR ) chronic rhinosinusitis ( CRS ) respectively ( 1 ) ( 2 ) . The currently available medication alleviate symptom associate AR RS , patient RS benefit endoscopic sinus surgery ( ESS ) . In real life , significant percentage patient AR CRS continue experience bothersome symptom despite adequate treatment . This group so-called severe chronic upper airway disease ( SCUAD ) represent therapeutic challenge ( 3 ) .</brief_summary>
	<brief_title>Long-term Control Rhinosinusitis After Functional Endoscopic Sinus Surgery ( FESS )</brief_title>
	<detailed_description />
	<criteria>1 . Patients undergone bilateral ESS inflammatory sinonasal disease , without additional sinonasal surgery ESS . 2 . Age &gt; 18 &lt; 75 year . 3 . Written inform consent 4 . Dutch , French English speaking patient 1 . Unilateral ESS 2 . Benign malignant tumor disease 3 . Patient psychiatric , addictive , disorder investigator feel time evaluation participation study may compromise ability give truly informed consent participation study provide reliable information questionnaire 4 . Lack knowledge Dutch , French English</criteria>
	<gender>All</gender>
	<minimum_age>19 Years</minimum_age>
	<maximum_age>74 Years</maximum_age>
	<verification_date>December 2014</verification_date>
</DOC>